← Eichor
Study identifier: NCT05927519 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study

Condition: Obesity, Morbid · Intubation; Difficult or Failed · Video Laryngoscope  ·  Sponsor: Kocaeli University

PhaseNA
Planned participants80
Who can joinMale, 18 Years to 80 Years
Healthy volunteersNo

About this study

Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, perioperative hemodynamic variables, and postoperative complications will also be recorded.

This description comes directly from the study's public registry record.

Talk to the study team

Zehra Arslan, professor  ·  00902623038168  ·  zehraipek48@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Kocaeli University Medical Faculty HospitalIamit, Turkey (Türkiye)Recruiting
Kocaeli UniversityMedical FacultyKocaeli, Turkey (Türkiye)Active Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05927519